RxDoctor Payments Data

Diane St Pierre

Family · Fort Myers, FLNPI 1427382761

Payments from drug & device makers

$840in general payments, 2019–2025

Across 46 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$205
  • Novo Nordisk$202
  • Amgen$191
  • Lilly USA, LLC$106
  • Merck$52
  • Dexcom, Inc.$21
  • plus $64 from 4 others

What the payments were for

  • Food & beverage$840100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$840 in reported general payments places this provider in the 65th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$207,006
Medicare patients
297
Services billed
5,227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide102$121,197
EliquisApixaban34$52,646
FarxigaDapagliflozin Propanediol43$48,725
XareltoRivaroxaban20$31,556
MounjaroTirzepatide17$18,026
JardianceEmpagliflozin14$16,092
Breo ElliptaFluticasone/Vilanterol14$9,430
SynthroidLevothyroxine Sodium53$4,328
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$4,111
Levothyroxine Sodium429$3,858
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,741
Atorvastatin Calcium276$2,534
Metoprolol Succinate114$1,813
Lisinopril206$1,554
Omeprazole88$1,498

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$202$121,197102 claims
PfizerEliquis$205$52,64634 claims
Johnson & JohnsonXarelto$18$31,55620 claims
Lilly USA, LLCMounjaro$106$18,02617 claims
GSKBreo Ellipta$14$9,43014 claims
Almatica Pharma LLCSertraline Hcl$16$82591 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 14,618 family providers in Florida.

Other family in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →